Use of a Computer in the New Drug Evaluation Process

  • Stewart J. Ehrreich
Part of the Developments in Cardiovascular Medicine book series (DICM, volume 47)

Abstract

The clinical reviewer for New Drug Applications (NDA) or Investigational New Drug Exemptions (IND’s) is faced with the sheer weight of the applications and NDA submissions have gone well above 1,000 volumes in size. Since each volume is about 500 pages long, this is about one half million pages to review.

Keywords

Placebo Lost 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© Martinus Nijhoff Publishing, Boston 1985

Authors and Affiliations

  • Stewart J. Ehrreich

There are no affiliations available

Personalised recommendations